Carcinosarcoma — Trials

Carcinosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

77 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 22
Recruiting: 13
Ph III recruiting: 5
Growth YoY: —
Industry share: 5%
Top sponsor: Mayo Clinic
Termination share: 46.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (15)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06483048	MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer	recruiting	Phase 1	12	Mayo ClinicOTHER	1	Mar 16, 2026	clinicaltrials
NCT05542407	ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer	recruiting	Phase 1	58	UNC Lineberger Comprehensive Cancer CenterOTHER	1	Jan 29, 2026	clinicaltrials
NCT05902988